MiR-378a suppresses tenogenic differentiation and tendon repair by targeting at TGF-β2.

Yang LiuLu FengJia XuZhengmeng YangTianyi WuJiajun ZhangLiu ShiDahai ZhuJinfang ZhangGang Li

Published in: Stem cell research & therapy (2019)

Our investigation suggests that miR-378a could be considered as a new potential biomarker for tendon injury diagnosis or drug target for a possible therapeutic approach in future clinical practice.

Keyphrases

cell proliferation
long non coding rna
clinical practice
long noncoding rna
anterior cruciate ligament reconstruction
rotator cuff
signaling pathway
current status
transforming growth factor
emergency department
adverse drug